Pyrazinamide contraindications: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 13: Line 13:
*with severe hepatic damage.
*with severe hepatic damage.
*who have shown hypersensitivity to it.
*who have shown hypersensitivity to it.
*with acute gout
*with acute gout


==References==
==References==

Revision as of 01:29, 4 January 2014

Pyrazinamide
PYRAZINAMIDE® FDA Package Insert
Description
Clinical Pharmacology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]


CONTRAINDICATIONS

Pyrazinamide is contraindicated in persons:[1]


  • with severe hepatic damage.
  • who have shown hypersensitivity to it.
  • with acute gout

References

  1. "PYRAZINAMIDE (PYRAZINAMIDE) TABLET [MIKART, INC.]".

Adapted from the FDA Package Insert.